The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Pathological bacterial translocation in liver cirrhosis
Open accessAbstract
Humans harbor nearly 100 trillion intestinal bacteria, which in terms of numbers, represents around ten times more microbial cells than eukaryotic cells. The gastrointestinal (GI) tract, the largest surface area of the body with an epithelial surface of approximately 400 m, is in constant exposure to these live microorganisms. Their peaceful coexistence demonstrated by the lack of pro-inflammatory responses against commensal bacteria implicates the presence of clearly defined lines of communication. In fact, bacterial translocation (BT), being defined as translocation of bacteria and/or bacterial products (lipopolysaccharides, peptidoglycans, muramyl-dipeptides, bacterial DNA, etc.) from the gut to mesenteric lymph nodes (MLN) [1], is a physiological process in healthy conditions and crucial for host immunity. In contrast, in cirrhosis ‘‘pathological’’ BT develops with a sustained increase in quantity (rate and/or degree) of BT. However, at least in humans, lack of access to MLN and/or upstream compartments towards the mucosal barrier until now hamper establishment of ‘‘cut-off’’ levels for physiological levels of BT in individual patients. Nonetheless, there appears to exist a hierarchy of three barriers against pathological BT, each of which encompasses a distinct set of mechanisms (Fig. 1). First, there are mediators that limit direct contact between the intestinal bacteria and the epithelial cell surface. Secondly, a layer of immune protection involves the rapid detection and killing of bacteria that manage to penetrate. Finally, a set of immune responses minimizes exposure of bacteria to the systemic immune system. In advanced liver cirrhosis, at each of these
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–208 of 208
Luyer, M. D. P., Buurman, W. A., Hadfoune, M., Wolfs, T. G. A. M., Veer, C. V. ′., Jacobs, J. A., Dejong, C. H. C., & Greve, J. W. M. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251513.59983.3b · Cited by 25
Gäbele, E., Mühlbauer, M., Paulo, H., Johann, M., Meltzer, C., Leidl, F., Wodarz, N., Wiest, R., Schölmerich, J., & Hellerbrand, C. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5558 · Cited by 24
Self-citationSensing microbes by diverse hosts: Workshop on Pattern Recognition Proteins and Receptors
Girardin, S. E., Philpott, D. J., & Lemaître, B. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor940 · Cited by 21
Where is the site of bacterial translocation--small or large bowel?
Koh, I. H. J., Guatelli, R., Montero, E. F. D. S., Keller, R., Silva, M. H. G., Goldenberg, S., & Silva, R. M. (1996) · PubMed · Cited by 19
Levi, A. C., Borghi, F., Petrino, R. A., Bargoni, A., Cm, F., & Gentilli, S. (1991) · PubMed · Cited by 18
The ability of endotoxin-stimulated enterocytes to produce bactericidal factors
Ogle, C. K., Noel, J. G., Guo, X., Wells, D. A., Valente, J. F., Ogle, J. D., & Alexander, J. W. (2002) · Critical Care Medicine · doi:10.1097/00003246-200202000-00027 · Cited by 14
Prabhu, R., & Balasubramanian, K. A. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2003.12.029 · Cited by 4
Bruns, T., Peter, J., Hagel, S., Pfeifer, R., Prinz, P., & Stallmach, A. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00850.x · Cited by 3
Cited by
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Self-citationEASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Angeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.024 · Cited by 2,905
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Albillos, A., Lario, M., & Álvarez-Mon, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.010 · Cited by 1,242
“Specifically, cirrhosis leads to increased intestinal permeability, due to compromised epithelial integrity, intestinal bacterial overgrowth and dysbiosis, caused by disruption of host microbiota homeostasis and intestinal and general immune defence impairment [97,98].”
Background
Metadata
- Authors
- Wiest, R., Lawson, M., & Geuking, M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 60
- Issue
- 1
- Pages
- 197-209
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2093795546
- Cited by
- 805
- References
- 208
- FWCI
- 23.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.